ArticleCancer immunology, immunotherapy : CII2023

XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour models.

Bochun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.